ZLAB zailaboratory.com Company Cash on Hand

zailaboratory.com - graphic logo of issuer ZLAB

Zai Lab Limited (ZLAB) integrates global medtech innovations with the optimization of Asian supply chains, creating a robust barrier for competitors in China. Free cash flow demonstrates financial resilience, while the 0.66 level captures fresh liquidity values. The business's biotechnological profile possesses defensive qualities, ensuring stable demand for therapy regardless of market volatility.

Company Cash Funds: Zai Lab Ltd (ZLAB) for 07/04/2022 - 11/21/2026

Analytical breakdowns for Zai Lab Ltd. (ZLAB)

- cash availability and cash flow indicators:
Fundamental valuation:ZLAB Zai Lab Limited
Brand item of Zai Lab Ltd

This indicator measures the volume of available cash and cash equivalents, determining the business's ability to withstand sudden market shocks without resorting to external borrowing. By analyzing the cash liquidity ratio, an investor assesses whether Zai Lab Limited (ZLAB) possesses sufficient capital to fund the large-scale implementation of automated research management systems and the modernization of biopharmaceutical hubs, which is critical given the high capital intensity of digital transformation.